Alfred D Kingsley is Chairman of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 5.47 Million shares of LCTX, which is worth approximately $2.74 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 61,800 shares (Common Shares, no par value) at a price of $2.2 per share, resulting in proceeds of $135,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.47M
0% 3M change
0% 12M change
Total Value Held $2.74 Million

ALFRED D KINGSLEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2021
BUY
Exercise of conversion of derivative security
$135,960 $2.2 p/Share
61,800 Added 1.12%
5,470,245 Common Shares, no par ...

Also insider at

OCX
Oncocyte Corp Healthcare
ADK

Alfred D Kingsley

Chairman
Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX